Advertisement

Topics

Trial of HIV prevention drugs to start in five locations in England

07:48 EDT 4 Aug 2017 | EPM Magazine

A three-year trial of the pre-exposure prophylaxis (PrEP) for the prevention of HIV infection has been announced by NHS England and will be the largest single study of its type in the world with an estimated 10,000 people expected to be included.

Original Article: Trial of HIV prevention drugs to start in five locations in England

NEXT ARTICLE

More From BioPortfolio on "Trial of HIV prevention drugs to start in five locations in England"

Quick Search
Advertisement
 

Relevant Topics

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...